KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Liabilities and Shareholders Equity: 2009-2024

Historic Liabilities and Shareholders Equity for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $7.5 billion.

  • Charles River Laboratories International's Liabilities and Shareholders Equity fell 6.12% to $7.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $30.2 billion, marking a year-over-year decrease of 6.55%. This contributed to the annual value of $7.5 billion for FY2024, which is 8.13% down from last year.
  • As of FY2024, Charles River Laboratories International's Liabilities and Shareholders Equity stood at $7.5 billion, which was down 8.13% from $8.2 billion recorded in FY2023.
  • In the past 5 years, Charles River Laboratories International's Liabilities and Shareholders Equity registered a high of $8.2 billion during FY2023, and its lowest value of $5.5 billion during FY2020.
  • For the 3-year period, Charles River Laboratories International's Liabilities and Shareholders Equity averaged around $7.8 billion, with its median value being $7.6 billion (2022).
  • Per our database at Business Quant, Charles River Laboratories International's Liabilities and Shareholders Equity climbed by 27.93% in 2021 and then decreased by 8.13% in 2024.
  • Charles River Laboratories International's Liabilities and Shareholders Equity (Yearly) stood at $5.5 billion in 2020, then increased by 27.93% to $7.0 billion in 2021, then increased by 8.24% to $7.6 billion in 2022, then climbed by 7.79% to $8.2 billion in 2023, then decreased by 8.13% to $7.5 billion in 2024.